Clinical Trial

Whole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease

Study acronym: PBM
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to exploratorily evaluate the extent of motor and cognitive changes, as well as the safety, resulting from approximately 10 weeks of whole-body photobiomodulation (PBM) therapy (about three sessions per week, once daily, 20 minutes per session) in patients with Parkinson's disease.
Trial Details
NCT Number NCT07271927
Lead Sponsor Pusan National University Yangsan Hospital
Conditions PARKINSON DISEASE (Disorder)
Enrollment 15 participants
Start Date 2025-02-12
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-09